nodes	percent_of_prediction	percent_of_DWPC	metapath
Minaprine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0914	0.151	CbGeAlD
Minaprine—DRD1—nerve—amyotrophic lateral sclerosis	0.0313	0.0517	CbGeAlD
Minaprine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.0238	0.0393	CbGeAlD
Minaprine—HTR2A—pons—amyotrophic lateral sclerosis	0.0235	0.0389	CbGeAlD
Minaprine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0201	0.0331	CbGeAlD
Minaprine—MAOA—nerve—amyotrophic lateral sclerosis	0.0187	0.0309	CbGeAlD
Minaprine—DRD2—nerve—amyotrophic lateral sclerosis	0.0185	0.0306	CbGeAlD
Minaprine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.0173	0.0285	CbGeAlD
Minaprine—HTR2A—appendage—amyotrophic lateral sclerosis	0.0172	0.0284	CbGeAlD
Minaprine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.0156	0.0259	CbGeAlD
Minaprine—MAOA—hindbrain—amyotrophic lateral sclerosis	0.014	0.0231	CbGeAlD
Minaprine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.0139	0.0229	CbGeAlD
Minaprine—DRD1—brainstem—amyotrophic lateral sclerosis	0.0134	0.0222	CbGeAlD
Minaprine—HTR2A—nerve—amyotrophic lateral sclerosis	0.0122	0.0202	CbGeAlD
Minaprine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.0104	0.0172	CbGeAlD
Minaprine—ACHE—medulla oblongata—amyotrophic lateral sclerosis	0.0102	0.0169	CbGeAlD
Minaprine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.0099	0.0164	CbGeAlD
Minaprine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00914	0.0151	CbGeAlD
Minaprine—ACHE—spinal cord—amyotrophic lateral sclerosis	0.00911	0.0151	CbGeAlD
Minaprine—MAOA—embryo—amyotrophic lateral sclerosis	0.00876	0.0145	CbGeAlD
Minaprine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00832	0.0138	CbGeAlD
Minaprine—MAOA—brainstem—amyotrophic lateral sclerosis	0.00803	0.0133	CbGeAlD
Minaprine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00794	0.0131	CbGeAlD
Minaprine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00728	0.012	CbGeAlD
Minaprine—ACHE—cerebellum—amyotrophic lateral sclerosis	0.00722	0.0119	CbGeAlD
Minaprine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00704	0.0116	CbGeAlD
Minaprine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00678	0.0112	CbGeAlD
Minaprine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00649	0.0107	CbGeAlD
Minaprine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.00615	0.0102	CbGeAlD
Minaprine—ACHE—brain—amyotrophic lateral sclerosis	0.00587	0.00969	CbGeAlD
Minaprine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00571	0.00944	CbGeAlD
Minaprine—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.0056	0.00925	CbGeAlD
Minaprine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00547	0.00904	CbGeAlD
Minaprine—DRD1—brain—amyotrophic lateral sclerosis	0.00538	0.00889	CbGeAlD
Minaprine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00527	0.0087	CbGeAlD
Minaprine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00524	0.00865	CbGeAlD
Minaprine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00518	0.00857	CbGeAlD
Minaprine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00516	0.00853	CbGeAlD
Minaprine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00514	0.00849	CbGeAlD
Minaprine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00499	0.00825	CbGeAlD
Minaprine—MAOA—spinal cord—amyotrophic lateral sclerosis	0.00499	0.00825	CbGeAlD
Minaprine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00497	0.00822	CbGeAlD
Minaprine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00495	0.00817	CbGeAlD
Minaprine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00477	0.00788	CbGeAlD
Minaprine—MAOA—nervous system—amyotrophic lateral sclerosis	0.00421	0.00695	CbGeAlD
Minaprine—HTR2C—brain—amyotrophic lateral sclerosis	0.00418	0.00691	CbGeAlD
Minaprine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00416	0.00687	CbGeAlD
Minaprine—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00405	0.00669	CbGeAlD
Minaprine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.004	0.00662	CbGeAlD
Minaprine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00396	0.00655	CbGeAlD
Minaprine—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00396	0.00654	CbGeAlD
Minaprine—CHRM1—brain—amyotrophic lateral sclerosis	0.00395	0.00652	CbGeAlD
Minaprine—HTR2B—brain—amyotrophic lateral sclerosis	0.00393	0.00649	CbGeAlD
Minaprine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00391	0.00647	CbGeAlD
Minaprine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00365	0.00603	CbGeAlD
Minaprine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00326	0.00538	CbGeAlD
Minaprine—MAOA—brain—amyotrophic lateral sclerosis	0.00321	0.00531	CbGeAlD
Minaprine—DRD2—brain—amyotrophic lateral sclerosis	0.00318	0.00525	CbGeAlD
Minaprine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.00274	0.00453	CbGeAlD
Minaprine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.00264	0.00436	CbGeAlD
Minaprine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.00258	0.00427	CbGeAlD
Minaprine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.0025	0.00413	CbGeAlD
Minaprine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00241	0.00398	CbGeAlD
Minaprine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00235	0.00389	CbGeAlD
Minaprine—HTR2A—brain—amyotrophic lateral sclerosis	0.0021	0.00346	CbGeAlD
Minaprine—CYP2D6—brain—amyotrophic lateral sclerosis	0.00191	0.00316	CbGeAlD
Minaprine—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00124	0.00315	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00123	0.0031	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00123	0.0031	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00116	0.00294	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00115	0.00292	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00115	0.00292	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.0011	0.0028	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—YIF1A—amyotrophic lateral sclerosis	0.00109	0.00277	CbGpPWpGaD
Minaprine—ACHE—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00109	0.00277	CbGpPWpGaD
Minaprine—ACHE—Peptide hormone metabolism—IGF1—amyotrophic lateral sclerosis	0.00106	0.0027	CbGpPWpGaD
Minaprine—ACHE—Phospholipid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00106	0.00269	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00104	0.00264	CbGpPWpGaD
Minaprine—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00103	0.00261	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00102	0.00258	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.000989	0.0025	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000951	0.00241	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000946	0.0024	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.000925	0.00234	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000914	0.00232	CbGpPWpGaD
Minaprine—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000914	0.00231	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—EXOSC9—amyotrophic lateral sclerosis	0.0009	0.00228	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000891	0.00226	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000889	0.00225	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000859	0.00217	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000841	0.00213	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00082	0.00208	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000793	0.00201	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000786	0.00199	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000773	0.00196	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000769	0.00195	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—TUBA4A—amyotrophic lateral sclerosis	0.000757	0.00192	CbGpPWpGaD
Minaprine—ACHE—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000743	0.00188	CbGpPWpGaD
Minaprine—ACHE—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000743	0.00188	CbGpPWpGaD
Minaprine—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0007	0.00177	CbGpPWpGaD
Minaprine—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0007	0.00177	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000698	0.00177	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000693	0.00176	CbGpPWpGaD
Minaprine—ACHE—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00068	0.00172	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000678	0.00172	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—DCTN1—amyotrophic lateral sclerosis	0.000644	0.00163	CbGpPWpGaD
Minaprine—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00064	0.00162	CbGpPWpGaD
Minaprine—ACHE—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000632	0.0016	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000599	0.00152	CbGpPWpGaD
Minaprine—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000595	0.00151	CbGpPWpGaD
Minaprine—ACHE—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000594	0.00151	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000589	0.00149	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000586	0.00148	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00058	0.00147	CbGpPWpGaD
Minaprine—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00056	0.00142	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000557	0.00141	CbGpPWpGaD
Minaprine—ACHE—Metabolism—DAO—amyotrophic lateral sclerosis	0.000537	0.00136	CbGpPWpGaD
Minaprine—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000506	0.00128	CbGpPWpGaD
Minaprine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000492	0.00125	CbGpPWpGaD
Minaprine—HTR2B—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000482	0.00122	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—IGFBP3—amyotrophic lateral sclerosis	0.000476	0.00121	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000475	0.0012	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000475	0.0012	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000462	0.00117	CbGpPWpGaD
Minaprine—DRD1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000454	0.00115	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000448	0.00113	CbGpPWpGaD
Minaprine—DRD2—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.000432	0.00109	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000431	0.00109	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000429	0.00109	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000407	0.00103	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000407	0.00103	CbGpPWpGaD
Minaprine—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000403	0.00102	CbGpPWpGaD
Minaprine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000398	0.00101	CbGpPWpGaD
Minaprine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000392	0.000994	CbGpPWpGaD
Minaprine—HTR2C—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000389	0.000985	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000384	0.000972	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000383	0.000971	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSR—amyotrophic lateral sclerosis	0.000376	0.000952	CbGpPWpGaD
Minaprine—HTR2B—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000367	0.00093	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000364	0.000922	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000354	0.000897	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000349	0.000884	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000348	0.000882	CbGpPWpGaD
Minaprine—DRD1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000346	0.000877	CbGpPWpGaD
Minaprine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000343	0.000869	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000342	0.000867	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000338	0.000857	CbGpPWpGaD
Minaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000338	0.000855	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000336	0.000852	CbGpPWpGaD
Minaprine—CHRM1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000336	0.000851	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000333	0.000843	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000331	0.000839	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000317	0.000803	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000316	0.000801	CbGpPWpGaD
Minaprine—ACHE—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000309	0.000782	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000307	0.000778	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000305	0.000772	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000305	0.000772	CbGpPWpGaD
Minaprine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000303	0.000769	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000302	0.000766	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000301	0.000762	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.0003	0.000759	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000298	0.000755	CbGpPWpGaD
Minaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000296	0.00075	CbGpPWpGaD
Minaprine—HTR2C—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000296	0.00075	CbGpPWpGaD
Minaprine—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000291	0.000737	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00029	0.000735	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000283	0.000716	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.000282	0.000713	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000279	0.000706	CbGpPWpGaD
Minaprine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000275	0.000697	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000274	0.000693	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000271	0.000687	CbGpPWpGaD
Minaprine—DRD2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000261	0.000662	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000259	0.000657	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000258	0.000653	CbGpPWpGaD
Minaprine—HTR2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000257	0.000651	CbGpPWpGaD
Minaprine—CHRM1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000256	0.000648	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000255	0.000646	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000255	0.000646	CbGpPWpGaD
Minaprine—DRD1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000246	0.000623	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000244	0.000617	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000243	0.000616	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000242	0.000613	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00024	0.000609	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000239	0.000607	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000236	0.000597	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000234	0.000594	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000234	0.000593	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000225	0.00057	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000222	0.000561	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.00022	0.000558	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00022	0.000558	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000213	0.000541	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000213	0.00054	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00021	0.000532	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000209	0.000529	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000208	0.000527	CbGpPWpGaD
Minaprine—HTR2B—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000207	0.000525	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000207	0.000524	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000206	0.000521	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000203	0.000515	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000202	0.000512	CbGpPWpGaD
Minaprine—ACHE—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000201	0.000509	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000201	0.000509	CbGpPWpGaD
Minaprine—DRD1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000196	0.000495	CbGpPWpGaD
Minaprine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.000193	0.000489	CbGpPWpGaD
Minaprine—HTR2B—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000188	0.000477	CbGpPWpGaD
Minaprine—DRD2—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000186	0.00047	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000184	0.000465	CbGpPWpGaD
Minaprine—CHRM1—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000182	0.00046	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000181	0.00046	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000181	0.000457	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00018	0.000455	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000179	0.000452	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000178	0.00045	CbGpPWpGaD
Minaprine—DRD1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000178	0.00045	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000175	0.000444	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000172	0.000435	CbGpPWpGaD
Minaprine—HTR2C—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000167	0.000424	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000167	0.000423	CbGpPWpGaD
Minaprine—ACHE—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000166	0.00042	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000165	0.000418	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000164	0.000416	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000156	0.000396	CbGpPWpGaD
Minaprine—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000156	0.000396	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000155	0.000392	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	0.000154	0.00039	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000152	0.000386	CbGpPWpGaD
Minaprine—HTR2C—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000152	0.000385	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000152	0.000384	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000149	0.000378	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000148	0.000376	CbGpPWpGaD
Minaprine—DRD2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000148	0.000374	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000148	0.000374	CbGpPWpGaD
Minaprine—HTR2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000145	0.000368	CbGpPWpGaD
Minaprine—CHRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000144	0.000366	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000144	0.000364	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000141	0.000358	CbGpPWpGaD
Minaprine—DRD2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000134	0.00034	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000134	0.000339	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000132	0.000336	CbGpPWpGaD
Minaprine—HTR2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000132	0.000334	CbGpPWpGaD
Minaprine—CHRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000131	0.000332	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000127	0.000321	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000126	0.00032	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000126	0.00032	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000126	0.000319	CbGpPWpGaD
Minaprine—ACHE—Metabolism—APOE—amyotrophic lateral sclerosis	0.000125	0.000318	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000125	0.000316	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000123	0.000311	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000122	0.000309	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000119	0.000301	CbGpPWpGaD
Minaprine—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	0.000118	0.000299	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000117	0.000296	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000115	0.000291	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000114	0.00029	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000111	0.000282	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000111	0.000282	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00011	0.000278	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000109	0.000276	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000108	0.000274	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000105	0.000266	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000104	0.000262	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000102	0.000257	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	9.77e-05	0.000247	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.53e-05	0.000241	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.38e-05	0.000238	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.33e-05	0.000236	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	8.97e-05	0.000227	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.96e-05	0.000227	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.82e-05	0.000223	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.77e-05	0.000222	CbGpPWpGaD
Minaprine—ACHE—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.59e-05	0.000218	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.56e-05	0.000217	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	8.35e-05	0.000212	CbGpPWpGaD
Minaprine—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.1e-05	0.000205	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	8.07e-05	0.000204	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.92e-05	0.000201	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.79e-05	0.000197	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.75e-05	0.000196	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.37e-05	0.000187	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.26e-05	0.000184	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.22e-05	0.000183	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.9e-05	0.000175	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.8e-05	0.000172	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.59e-05	0.000167	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.25e-05	0.000158	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.22e-05	0.000158	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	6.21e-05	0.000157	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6.09e-05	0.000154	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	6e-05	0.000152	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.96e-05	0.000151	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.87e-05	0.000149	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.59e-05	0.000142	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	5.31e-05	0.000135	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	5.27e-05	0.000134	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	5.14e-05	0.00013	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	5.02e-05	0.000127	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.69e-05	0.000119	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.61e-05	0.000117	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.59e-05	0.000116	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	4.51e-05	0.000114	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.43e-05	0.000112	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.36e-05	0.00011	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.34e-05	0.00011	CbGpPWpGaD
Minaprine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.22e-05	0.000107	CbGpPWpGaD
Minaprine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.98e-05	0.000101	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.98e-05	0.000101	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.92e-05	9.92e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.89e-05	9.87e-05	CbGpPWpGaD
Minaprine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.52e-05	8.93e-05	CbGpPWpGaD
Minaprine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.41e-05	8.63e-05	CbGpPWpGaD
Minaprine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	3.01e-05	7.62e-05	CbGpPWpGaD
Minaprine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.96e-05	7.5e-05	CbGpPWpGaD
Minaprine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.94e-05	7.46e-05	CbGpPWpGaD
